To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
10 Current news of Siemensrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
High-value specialty chemicals produced from CO2 and water using electricity from renewable sources and bacteria
Evonik and Siemens launched their joint research project Rheticus II. The goal is to develop an efficient and powerful test plant that will use carbon dioxide and water as well as electricity from renewable sources and bacteria to produce specialty chemicals (CO2). In the Rheticus I project, the ...
Siemens becomes a preferred supplier for automation solutions
The Siemens technology group andSartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim Biotech will preferably use Siemens automation ...
Siemens AG is preparing to list its separately managed healthcare unit on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. This move, which the company's Supervisory Board approved at its meeting today, is planned for the first half of 2018. "For Siemens ...
Siemens Healthineers and Biogen announce agreement to jointly develop new MRI tools for multiple sclerosis
Siemens Healthineers and Biogen announced that the companies plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Siemens Healthineers aims to enable healthcare providers to ...
Siemens will invest $300M over the next four years
Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility. "The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint ...
Siemens Healthcare GmbH enters field of molecular services for oncology
Siemens Healthineers has expanded its diagnostics portfolio with the acquisition of NEO New Oncology AG, Cologne, Germany. The company's cancer genome diagnostic platform NEO will support pathologists and oncologists with comprehensive molecular information to help select targeted cancer ...
Stronger concentration of Diagnostics Division on core business
Siemens Healthcare is selling its microbiology business to Beckman Coulter Inc., a wholly owned subsidiary of Danaher Corporation. The activities of the microbiology business include systems for the identification and antibiotic susceptibility testing (ID/AST) of microorganisms. The decision ...
New programme aims to help companies increase productivity with technology solutions for pharmaceutical and chemical sectors
Pfizer Asia Pacific Pte. Ltd, Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. Ltd, have signed on as founding members of a new A*STAR R&D Consortium Programme - Innovative Processing of Specialties and Pharmaceuticals (iPSP). Launched by A*STAR’s Institute of Chemical and Engineering ...
Siemens' researchers have been able to analyze blood cells by employing the same magnetic reading technology as is used for computer hard drives. They have developed a prototype for the magnetic flow cytometry of blood. Blood is the most important source of diagnostic information for doctors ...
Specialty Laboratories, Inc. will participate as a U.S. site for a joint working group on molecular diagnostics initiated by SEQUENOM, Inc. and Siemens Medical Solutions of Siemens AG. This collaboration combines the specialized assets and resources of the three organizations. Siemens Medical ...